SUPER9 Trademark

Trademark Overview


On Tuesday, April 9, 2019, a trademark application was filed for SUPER9 with the United States Patent and Trademark Office. The USPTO has given the SUPER9 trademark a serial number of 88377849. The federal status of this trademark filing is REGISTERED as of Tuesday, January 7, 2020. This trademark is owned by uniQure IP B.V.. The SUPER9 trademark is filed in the Pharmaceutical Products category with the following description:

Medicinal preparations for treatment of hemophilia A, namely, viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors; Viral systems, gene therapy systems, nucleic acid delivery systems for medical purposes, namely, medicines for the treatment of hemophilia A; Pharmaceutical preparations and substances for the treatment of hemophilia A; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy for the treatment of hemophilia A; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing; pharmaceutical preparations, vaccines, prophylaxis medicines and other pharmaceutical preparations all for use in nucleic acid-based therapy, gene therapy and cell therapy fo...
super9

General Information


Serial Number88377849
Word MarkSUPER9
Filing DateTuesday, April 9, 2019
Status700 - REGISTERED
Status DateTuesday, January 7, 2020
Registration Number5953493
Registration DateTuesday, January 7, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 22, 2019

Trademark Statements


Goods and ServicesMedicinal preparations for treatment of hemophilia A, namely, viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors; Viral systems, gene therapy systems, nucleic acid delivery systems for medical purposes, namely, medicines for the treatment of hemophilia A; Pharmaceutical preparations and substances for the treatment of hemophilia A; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy for the treatment of hemophilia A; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing; pharmaceutical preparations, vaccines, prophylaxis medicines and other pharmaceutical preparations all for use in nucleic acid-based therapy, gene therapy and cell therapy for the treatment of hemophilia A
Pseudo MarkSUPER NINE

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 25, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameUNIQURE BIOPHARMA B.V.
Party Type31 - New Owner After Registration
Legal Entity Type26 - NOT AVAILABLE
AddressAMSTERDAM 1105BP
NL

Party NameuniQure IP B.V.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAmsterdam 1105BP
NL

Party NameuniQure IP B.V.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAmsterdam 1105BP
NL

Party NameuniQure IP B.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAmsterdam 1105BP
NL

Trademark Events


Event DateEvent Description
Friday, April 12, 2019NEW APPLICATION ENTERED
Thursday, April 25, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 19, 2019ASSIGNED TO EXAMINER
Monday, June 24, 2019NON-FINAL ACTION WRITTEN
Monday, June 24, 2019NON-FINAL ACTION E-MAILED
Monday, June 24, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 5, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 14, 2019ASSIGNED TO LIE
Friday, August 16, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 16, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 5, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 6, 2019ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Monday, September 16, 2019ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, October 2, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 22, 2019PUBLISHED FOR OPPOSITION
Tuesday, October 22, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 7, 2020REGISTERED-PRINCIPAL REGISTER
Friday, May 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 26, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, May 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 26, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, May 26, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 26, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 7, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, June 4, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 4, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 4, 2025TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, June 4, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 4, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 4, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 4, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, June 11, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP